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ABSTRACT
Objective: The study aimed to verify the hypoglycemic effect of Murraya koenigii (M. koenigii) and 
Catharanthus roseus (C. roseus) by using various in-vitro techniques.
Method: The extracts were studied for their effects on glucose adsorption capacity, in-vitro glucose dif-
fusion, in-vitro amylolysis kinetics and glucose transport across the yeast cells. 
Results: It was observed that the extracts of M. koenigii and C. roseus adsorbed glucose and the adsorp-
tion of glucose increased remarkably with an increase in glucose concentration. There were no significant 
(p≤0.05) differences between their adsorption capacities. In the amylolysis kinetic experimental model 
the rate of glucose diffusion was found to be increased with time from 30 to 180 min and both the plant 
extracts exhibited significant inhibitory effects on the movement of glucose into external solution across 
the dialysis membrane as compared to control. The extracts also promoted glucose uptake by the yeast 
cells and the enhancement of glucose uptake was dependent on both the sample and glucose concentra-
tion. The extract of M. koenigii exhibited significantly higher (p≤0.05) activity than the extract of C. ro-
seus at all concentrations used in the study. Our report suggests the mechanism(s) for the hypoglycemic 
effect of M. koenigii and C. roseus. 
Conclusion: The said effect was observed to be mediated by inhibiting alpha amylase, inhibiting glu-
cose diffusion by adsorbing glucose and by increasing glucose transport across the cell membranes as 
revealed by in-vitro model of yeast cells. However, these effects need to be affirmed by using different in 
vivo models and clinical trials.
Keywords: Hypoglycemic; Glucose diffusion; M. koenigii; C. roseus.
RESUMEN
Objetivo: El estudio tuvo como objetivo verificar el efecto hipoglucémico de Murraya koenigii (M. koe-
nigii) y Catharanthus roseus (C. roseus) mediante el uso de diversas técnicas in vitro.
Método: Los extractos se estudiaron por sus efectos sobre la capacidad de adsorción de glucosa, la di-
fusión de glucosa in vitro, la cinética de amilolisis in vitro y el transporte de glucosa a través de las 
células de levadura.
Resultados: se observó que los extractos de M. koenigii y C. roseus adsorbieron glucosa y la adsorción 
de glucosa aumentó notablemente con un aumento en la concentración de glucosa. No hubo diferen-
cias significativas (p≤0.05) entre sus capacidades de adsorción. En el modelo experimental cinético de 
amilolisis, se encontró que la velocidad de difusión de glucosa aumentaba con el tiempo de 30 a 180 
min y ambos extractos de planta exhibían efectos inhibitorios significativos sobre el movimiento de la 
glucosa hacia la solución externa a través de la membrana de diálisis en comparación con el control. 
Los extractos también promovieron la absorción de glucosa por las células de levadura y la mejora de 
la captación de glucosa dependió tanto de la muestra como de la concentración de glucosa. El extracto 
de M. koenigii exhibió una actividad significativamente mayor (p≤0.05) que el extracto de C. roseus en 
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todas las concentraciones utilizadas en el estudio. Nuestro informe 
sugiere el mecanismo (s) para el efecto hipoglucemiante de M. koe-
nigii y C. roseus.
Conclusión: Se observó que dicho efecto estaba mediado por la 
inhibición de la alfa amilasa, la inhibición de la difusión de glucosa 
por la adsorción de glucosa y el aumento del transporte de gluco-
sa a través de las membranas celulares según lo revelado por el 
modelo in vitro de células de levadura. Sin embargo, estos efectos 
deben ser afirmados mediante el uso de diferentes modelos in vivo 
y ensayos clínicos
Palabras clave: hipoglucemiante; Difusión de glucosa; M. koenigii; 
C. roseus.
INTRODUCTION
Diabetic mellitus is the condition arising due to abnormal 
metabolism of carbohydrate, proteins and fats. It is caused 
by insulin deficiency, often combined with insulin resist-
ance1.
As the number of the people with diabetes multiplies 
worldwide, the disease has taken an ever-increasing share 
of national and international health care budgets2. It is pro-
jected to become of the world’s main disablers and killers 
within the next 25 years3, 4.
Currently, the treatments of diabetes, in addition to insulin 
supplement mainly include many oral hypoglycemic agents 
like sulfonylureas, biguanides, thiazolidines, D-phenylala-
nine derivatives, meglitinides and α-glucosidase inhibitors 
along with an appropriate diet and exercise. However, none 
can be considered to be the ideal one, due to their toxic side 
effects and sometimes diminution in response after pro-
longed use5, 6. Therefore, continuous efforts are being made 
to develop new compounds or combinations especially of 
herbal origin. Plants represent a vast source of potentially 
useful dietary supplements for improving blood glucose 
control and preventing long-term complications in type 2 
diabetes mellitus7, 8. Traditional plant medicines are used 
throughout the world for a range of diabetic presentation. 
Numerous plants have been documented as beneficial in 
the treatment of diabetes8. However, the majority of tradi-
tional antidiabetic plants still await a proper scientific and 
medical evaluation of their ability to improve blood glu-
cose control and or to prevent the diabetic complications9. 
Thus, there is a vital need to undertake a systematic study 
so as to explore the possible mechanism(s) of action of the 
traditional anti-diabetic plants.
Murraya koenigii, belonging to the family Rutaceae, com-
monly known as curry-leaf tree, is a native of India, Sri 
Lanka and other south Asian countries10. It is found almost 
everywhere in the Indian subcontinent. It shares the aro-
matic nature, more or less deciduous shrub or tree up to 
6 m in height and 15-40 cm in diameter with short trunk, 
thin, smooth gray or brown bark and dense shady crown11.
The plant has been reported to exhibit a wide array of ac-
tivities including antidiabetic, hypocholesterolemic and in 
vivo hypoglycemic activity, etc.12-19. The green leaves of the 
plant are used to treat piles, inflammation, itching, fresh 
cuts, dysentery, vomiting and dropsy15, 16.
Catharanthus roseus L., which belongs to family Apocynace-
ae, is commonly known as ‘periwinkle’. It is an important 
source of indole alkaloids, which are present in all plant 
parts17. It has been used for the treatment of diabetes, fever, 
malaria, throat infections, and chest complaints. It is also 
used for the regulation of menstrual cycles, and as a eu-
phoriant18. The physiologically important and antineoplas-
tic alkaloids namely Vincristine and Vinblastine are mainly 
present in the leaves whereas antihypertensive alkaloids 
such as ajmalicine, serpentine, and reserpine are reported 
to be present in the roots17, 19. Vincristine and Vinblastine 
alkaloids are used in the treatment of various types of lym-
phoma and leukemia17, 20-22.
The present study was therefore, undertaken to verify the 
hypoglycemic potential of the leaves of M. koenigii and C. 
roseus by using various in-vitro techniques to explore their 
probable mechanism(s) of action.
MATERIALS AND METHODS
Chemicals and reagents 
Glucose oxidase peroxidase kit was purchased from 
Pathozyme Diagnostics, Kagal, Maharashtra, India. Dial-
ysis bags (12,000 MW cutoff; Himedia laboratories, India) 
were used in the study. All the chemicals used in the pres-
ent study were of extra pure analytical grade.
Plant material 
The leaves of M. koenigii and C. roseus were collected from 
the local areas of Kasegaon, District Sangli, (MS), India. The 
plant material was further identified and authenticated by 
the Department of Botany, Yashwantrao Chavan College of 
Science, Karad. The leaves of M. koenigii and C. roseus were 
cleaned thoroughly, dried in a hot air oven (50 °C), pow-
dered, passed through 60 mesh sieve (BS) and stored in an 
airtight container at 4 °C till further use.
Preparation of plant extracts
Aqueous extracts were prepared by extracting the powders 
of leaves of M. koenigii and C. roseus with hot water (70 °C) 
in a mechanical shaker (24 h), filtered and freeze dried.
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Evaluation of hypoglycemic activity of plant extracts 
using various in vitro methods 
Determination of glucose adsorption capacity
The samples of plant extracts (1%) were added to 25 ml of 
glucose solution of increasing concentration (5, 10, 20, 50 
and 100 mM) 9. The mixture was stirred well, incubated in 
a shaker water bath at 37 °C for 6 h, centrifuged at 4,000×g 
for 20 min and the glucose content in the supernatant was 
determined9, 23, 24. The concentration of bound glucose was 
calculated using the following formula25.
Glucose Bound =
G1  -   G6
Weight of the sample  
X Volume of solution    
G1 is the glucose concentration of the original solution.
G6 is the glucose concentration after 6 hr.
Effect of plant extracts on in-vitro glucose diffusion 
25 ml of glucose solution (20 mM) and the samples of plant 
extracts (1%) were dialyzed in dialysis bags against 200 ml 
of distilled water at 37 °C in a shaker water bath9, 23, 26. The 
glucose content in the dialysate was determined at 30, 60, 
120 and 180 min using glucose oxidase peroxidase diagnos-
tic kit9, 23, 26. A control test was carried out without sample. 
Glucose dialysis retardation index (GDRI) was calculated 
by using the following formula23, 24.
GDRI = 100 -
Glucose content with addition of sample (mg/dl)
Glucose content of the control (mg/dl)
X 100
Effect of plant extracts on in-vitro amylolysis kinetics 
40 grams of potato starch was added to ≈900 ml of 0.05 M phos-
phate buffer (pH 6.5)9, 27. The solution after stirring at 65 °C for 
30 min was made up to a final volume of 1000 ml to give a 4% 
(w/v) starch solution. 25 ml of the above starch solution, α-amyl-
ase (0.4%), and the plant extracts (1%) were dialyzed in a dial-
ysis bags against 200 ml of distilled water at 37 °C (pH 7.0) in 
a shaker water bath9, 23, 26. The glucose content in the dialysate 
was determined at 30, 60, 120 and 180 min. A control test was 
carried out without sample9, 23, 25, 26. Glucose dialysis retardation 
index (GDRI) was determined by using the formula mentioned in 
the method of in-vitro glucose diffusion. 
Glucose uptake by yeast cells 
Commercial baker’s yeast was washed by repeated centrif-
ugation (3,000×g; 5 min) in distilled water until the super-
natant fluids were clear and a 10% (v/v) suspension was 
prepared in distilled water9, 26. Various concentrations of 
extracts (1–5 mg) were added to 1 ml of glucose solution 
(5–25 mM) and incubated together for 10 min at 37 °C. The 
reaction was started by adding 100 μl of yeast suspension, 
vortexed and further incubated at 37 °C for 60 min9, 23, 26. Af-
ter 60 min, the tubes were centrifuged (2,500 × g, 5 min) and 
glucose was estimated in the supernatant9, 26. The percent 
increase in glucose uptake by yeast cells was calculated us-
ing the following formula24, 28.
Increase in glucose uptake (%)=
Absorbance control - Absorbance sample
Absorbance control
X 100
Where, Abs control is the absorbance of the control reaction 
(containing all reagents except the test sample), and Abs 
sample is the absorbance of the test sample.
Statistical analysis 
All the determinations were carried out in triplicates and 
the data were analyzed by ANOVA followed by Tukey’s 
multiple comparisons test for significant differences. Val-
ues were considered at p< 0.05. Graphs were plotted using 
Graph Pad Prism 6 software.
RESULTS AND DISCUSSION
The results of the glucose adsorption capacity exhibited 
by the selected plant extracts are represented in Figure 1. 
The results of the studies on glucose adsorption capacity 
showed that the extracts of M. koenigii and C. roseus could 
bind glucose effectively. The glucose adsorption capacity 
shown by the extracts was found to be directly proportion-
al to the glucose concentration. It was also revealed that 
both the plant extracts were effective in adsorbing glucose 
at both low and higher concentrations namely 5 and 100 
mmol L-1 glucose used in the study. The glucose adsorption 
capacity of the selected plant extracts was observed to be 
directly proportional to the molar concentration of glucose9, 
23, 26. A relatively higher amount of glucose was found to be 
bound with an increased glucose concentration. No signifi-
cant (p≤0.05) differences were marked between the adsorp-
tion capacities of M. koenigii and C. roseus. It was also indi-
cated from the study that the extracts of M. koenigii and C. 
roseus could effectively bind glucose even at lower concen-
trations of glucose (5 mM) thereby decreasing the amount 
of glucose and retarding its transport across the intestinal 
lumen. Thus, it contributes in blunting the postprandial hy-
perglycemia. The present findings are in accordance to the 
observations reported for insoluble fiber-rich fractions iso-
lated from Averrhoa carambola and aqueous extract of bark 
of Albizzia lebbeck7, 9, 23, 29.
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Figure 1: Glucose binding capacity of M. koenigii and C. roseus at different concentrations of glucose. Values are mean + SD of triplicate 
determinations
Table 1: Effect of selected samples on glucose diffusion and glucose dialysis retardation index
Sample
 Glucose content in dialysate (mM)
30min 60min 120min 180min
Control 0.81c+0.01 1.39c+0.01 1.60c+0.01 1.93c+0.01
M. koenigii 0.43a+0.01(46.92) 1.05a+0.01 (24.47) 1.39a+0.01(13.13) 1.73a+0.01(10.37)
C. roseus 0.48b+0.01(40.75) 1.11b+0.01 (20.15) 1.44b+0.01(10.0) 1.85b+0.01(4.15)
Values in parenthesis indicate glucose dialysis retardation index (GDRI)
Mean values (n=3) with different superscript letters in columns differ significantly from each other (p≤0.05)
Table 1 highlights the results of the effect of the extracts of M. koenigii and C. roseus on in-vitro glucose diffusion. The move-
ment of glucose diffusion across the dialysis membrane was monitored once in 30 min till 180 min9, 23, 26.The rate of diffu-
sion of glucose across the dialysis membrane was found to increase with time from 30 to 180 min9, 26. Both the samples of 
plant extracts exhibited significant inhibitory effects on movement of glucose into the external solution across the dialysis 
membrane as compared to9, 23, 26. GDRI was determined on the basis of the retardation of glucose diffusion. It was observed 
that the retardation of glucose diffusion by the extract of M. koenigii was significantly higher (p≤0.05) than C. roseus. The 
aforesaid effect of the extract of M. koenigii was reflected with its higher glucose dialysis retardation index (GDRI) value 
than those observed for the extract of C. roseus.
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Table 2: Effect of selected samples on starch digestibility and glucose dialysis retardation index
Sample
Glucose content in dialysate(mM)
30 min 60 min 120 min 180 min
Control 0.0 0.25c+0.01 0.33c+0.01 0.43c+0.01
M. koenigii 0.0 (100) 0.14a+0.01 (44.0) 0.24a+0.01(27.28) 0.37a+0.01(13.96)
C. roseus 0.0 (100) 0.18b+0.01 (28.0) 0.27b+0.01(18.19) 0.40b+0.01(6.98)
Values in parenthesis indicate glucose dialysis retardation index (GDRI)
Mean values (n=3) with different superscript letters in columns differ significantly from each other (p≤0.05)
Table 2 illustrates the effects of extracts of M. koenigii and 
C. roseus on the amylolysis kinetics model. Glucose dialy-
sis retardation index (GDRI) which is determined on the 
basis of the retardation of diffusion of glucose diffusion, is 
considered to be an important in -vitro index to assess the 
effect of a fiber on the delay in glucose absorption in the 
gastrointestinal tract9, 23, 26, 33. A relatively higher GDRI indi-
cates a higher retardation index of glucose by the sample. 
The GDRI was observed to be 44.0% and 29.0% for M. koe-
nigii and C. roseus respectively at 60 min which gradually 
got reduced to 27.28% and 18.19% respectively at 120 min. 
Several possible factors have been mentioned that may be 
responsible for the inhibition of alpha amylase enzyme; 
namely fiber concentration, the presence of inhibitors on 
fibers, encapsulation of starch and enzyme by the fibers 
present in the sample, thereby reducing accessibility of 
starch to the enzyme, and direct adsorption of the enzyme 
on fibers, leading to decreased amylase activity9, 23, 25, 26.
Our observations greatly emphasize that inhibition of the 
alpha amylase enzyme may be one of the probable mech-
anisms through which the extracts of M. koenigii and C. ro-
seus exert their hypoglycemic effect. The inhibitors of car-
bohydrate hydrolyzing enzymes promotes a delay in the 
digestion of carbohydrate thereby prolonging the overall 
carbohydrate digestion time to cause a reduction in the rate 
of absorption of glucose and consequently blunting the 
postprandial plasma glucose rise23, 26, 34, 35. Several inhibitors 
of alpha amylase enzyme have been recently developed 
from natural sources and some of them in clinical use are 
Acarbose, Miglitol and Voglibose35.
Figure 2: Effect of M. koenigii and C. roseus extract on the uptake of glucose by yeast cells. Values are mean ± SD of triplicate determina-
tions
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Figure 2 highlight the rate of glucose transport across cell 
membrane in yeast cells system for the extracts of M. koe-
nigii and C. roseus. The mechanism of transport of glucose 
across the yeast cell membrane have received attention and 
has been considered as an important technique for in-vitro 
screening of hypoglycemic activity of various compounds/ 
medicinal plants9, 23, 26. The results of the study revealed that 
both the extracts under study promoted transport of glu-
cose across the yeast cells. The amount of glucose which 
remains in the medium after a specific time interval acts as 
a measure of the glucose uptake by the yeast cells9, 23, 26. The 
rate of uptake of glucose into the yeast cells was found to be 
linear in all the 5 glucose concentrations used in this study. 
It was observed that the extracts of M. koenigii and C. roseus 
has improved glucose uptake by Saccharomyces cerevisiae 
yeast cells in a dose-dependent manner, with improved 
glucose uptake increasing proportionally as the concentra-
tion of glucose in the medium increases9, 23, 26. However, the 
extract of M. koenigii exhibited significantly higher (p≤0.05) 
activity than the extract of C. roseus at all concentrations 
used in the study. The percent increase in the uptake of 
glucose by the yeast cells was found to be inversely pro-
portional to the concentration of glucose and got decreased 
with an increase in the molar concentration of the glucose 
solution. Previous studies involving the transport of non 
metabolizable sugars, metabolizable glycosides have sug-
gested that the transport of sugar across the yeast cell mem-
brane is mediated by stereo specific membrane carriers and 
usually takes place by the process of facilitated diffusion23, 
31, 32, 36.
CONCLUSION
In conclusion, the results of the present investigation high-
lighted the hypoglycemic activity of M. koenigii and C. ro-
seus as assessed by various in-vitro methods. Inspite of the 
fact that in-vitro screening is not a reliable predictor of hy-
poglycemic effect in vivo, the various model systems used 
in the present study would provide an insight on the pos-
sible mechanism by which the extracts of M. koenigii and C. 
roseus may contribute in lowering the postprandial glucose 
levels. The hypoglycemic effect exhibited by the extracts of 
M. koenigii and C. roseus is observed to be mediated by in-
creasing glucose adsorption, decreasing glucose diffusion 
rate and at the cellular level by promoting the transport of 
glucose across the cell membrane as highlighted by em-
ploying simple in-vitro model of yeast cells. These observed 
effects further, need to be confirmed by employing different 
in vivo models and clinical trials which may contribute for 
their effective utilization as an adjunct in effective manage-
ment of diabetes mellitus.
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